Unstimulated high sensitive thyroglobulin measurement predicts outcome of differentiated thyroid carcinoma

Clinical Chemistry and Laboratory Medicine

Volumn 47, Issue 8, 2009, Pages 1001-1004

  Giovanella, Luca ^a   Maffioli, Marco ^b   Ceriani, Luca ^a   De Palma, Diego ^b   Spriano, Giuseppe ^c  

^a ONCOLOGY INSTITUTE OF SOUTHERN SWITZERLAND   (Switzerland)

^b OSPEDALE DI CIRCOLO   (Italy)

^c REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Differentiated thyroid carcinoma (DTC); Follow up; Thyroglobulin (Tg); Thyroid

Indexed keywords

THYROGLOBULIN;

ADULT; ARTICLE; CANCER RECURRENCE; CONTROLLED STUDY; FEMALE; FOLLICULAR CARCINOMA; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PAPILLARY CARCINOMA; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; THYROGLOBULIN BLOOD LEVEL; THYROID CARCINOMA;

ADULT; AGED; CARCINOMA; FEMALE; HUMANS; IMMUNORADIOMETRIC ASSAY; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROSPECTIVE STUDIES; THYROGLOBULIN; THYROID NEOPLASMS; THYROTROPIN; THYROXINE;

EID: 70349490116     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2009.216     Document Type: Article

References (15)

1. Mazzaferri E, Robbins RJ, Spencer CA, Bravermann LE, Pacini F, Wartofsky L, et al. A consensus report of the role of serum thyroglobulin as a monitoring method for lowrisk patients with papillary thyroid carcinoma. J Clin Endocrinol Metab 2003;88:1433-1441 (Pubitemid 36623351)
2. Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JW, Wiersinga W, et al. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 2006;154:787-803.
3. Souza do Rosario PW, Ribeiro Borges MA, Fagundes TA, Franco AC, Purisch S. Is stimulation of thyroglobulin (Tg) useful in low-risk patients with thyroid carcinoma and undetectable Tg on thyroxin and negative neck ultrasound? Clin Endocrinol 2005;62:121-125
4. Persoon AC, Jager PL, Sluiter WJ, Plukker JT, Wolffenbuttel BH, Links TP. A sensitive Tg assay or rhTSH stimulated Tg: what's the best in the long-term follow-up of patients with differentiated thyroid carcinoma? PLoS ONE 2007;2:e816. Accessed Oct 6, 2008.
5. Giovanella L, Ceriani L, Ghelfo A, Maffioli M, Keller F, Spriano G. Thyroglobulin assay during thyroxine treatment in low-risk differentiated thyroid cancer management: comparison with recombinant thyrotropinstimulated assay and imaging procedures. Clin Chem Lab Med 2006;44:648-652
6. Smallridge RC, Meek S, Morgan MA, Gates GS, Fox TP, Grabe S, et al. Monitoring thyroglobulin in a sensitive immunoassay has comparable sensitivity to recombinant human TSH-stimulated thyroglobulin in follow-up of thyroid cancer patients. J Clin Endocrinol Metab 2007;92:82-87
7. Iervasi A, Iervasi G, Ferdeghini M, Solimeo C, Bottoni A, Rossi L, et al. Clinical relevance of highly sensitive Tg assay in monitoring patients treated for differentiated thyroid cancer. Clin Endocrinol 2007;67:434-441
8. Mazzaferri EL. Will highly sensitive thyroglobulin assays change the management of thyroid cancer? Clin Endocrinol 2007;67:321-323
9. Giovanella L, Ceriani L. High-sensitivity human thyroglobulin (hTG) immunoradiometric assay in the follow-up of patients with differentiated thyroid cancer. Clin Chem Lab Med 2002;40:480-484 (Pubitemid 34693089)
10. Morgenthaler NG, Froelich J, Rendl J, Willnich M, Alonso C, Bergmann A, et al. Technical evaluation of a new immunoradiometric and a new immunoluminometric assay for thyroglobulin. Clin Chem 2002;48:1077-1083
11. Rosario PW, Purisch S. Does a highly sensitive thyroglobulin (Tg) assay change the clinical management of lowrisk patients with thyroid cancer with Tg on T4-1 ng/ mL determined by traditional assays? Clin Endocrinol 2008;68:338-342
12. Giovanella L. Highly sensitive thyroglobulin measurements in differentiated thyroid carcinoma management. Clin Chem Lab Med 2008;46:1067-1073
13. Schlumberger M, Hitzel A, Toubert ME, Corone C, Troalen F, Schlageter MH, et al. Comparison of seven serum thyroglobulin assays in the follow-up of papillary and follicular thyroid cancer patients. J Clin Endocrinol Metab 2007;92:2487-2495
14. Zophel K, Wunderlich G, Smith BR. Serum thyroglobulin measurements with high sensitivity enzyme-linked immunosorbent assay: is there a clinical benefit in patients with differentiated thyroid carcinoma? Thyroid 2003;13:861-865
15. Mazzaferri EL, Shiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid carcinoma. Am J Med 1994;97:418-428